Call for Papers
Inviting breakthrough research across all areas of oncology and cancer biology.
Advance the Frontiers of Cancer Science
The Journal of Neoplasms welcomes original contributions from oncologists, cancer biologists, translational researchers, and clinical investigators worldwide. From molecular mechanisms to clinical translation, JN is the premier platform for discoveries that transform cancer care.
Rapid peer review. Immediate Open Access. Global impact on patient outcomes.
Tumor Biology
- Cancer genomics and epigenetics
- Oncogene and tumor suppressor pathways
- Tumor microenvironment
- Metastasis mechanisms
- Cancer stem cells
- Resistance mechanisms
Novel Treatments
- Immunotherapy and checkpoint inhibitors
- CAR-T and cellular therapies
- Targeted molecular agents
- Antibody-drug conjugates
- Combination strategies
- Overcoming drug resistance
Patient Care
- Clinical trial results
- Precision oncology approaches
- Biomarker development
- Survivorship research
- Palliative and supportive care
- Health disparities in oncology
Original Research
Full-length studies with novel findings advancing cancer biology understanding or clinical practice. Preclinical through phase III trial reports welcome.
Review Articles
Comprehensive analyses synthesizing current knowledge on specific oncology topics with critical evaluation and future research directions.
Case Reports
Exceptional cases with novel presentations, unexpected treatment responses, or important diagnostic insights advancing clinical practice.
Methods Papers
Detailed protocols for cancer research techniques, novel assays, and improved methodologies benefiting the oncology research community.
Featured Topic: The immunotherapy transformation of oncology practice continues accelerating. We invite manuscripts on next-generation checkpoint combinations, novel cellular therapies, cancer vaccines, bispecific antibodies, and strategies to overcome primary and acquired resistance to immune-based treatments.
Biomarker-driven therapy selection represents the future of cancer care. JN actively solicits research on companion diagnostics, liquid biopsy applications, circulating tumor DNA monitoring, pharmacogenomics, and implementation of precision medicine in diverse clinical settings including community oncology practices.
Rapid Review
Average time to first decision under 21 days. Efficient editorial workflow respects your time while maintaining rigorous peer review by oncology experts.
Immediate Impact
Accepted articles published online within days. Open Access ensures your findings reach the global oncology community instantly for patient benefit.
Enhanced Visibility
Indexed in major databases. Social media promotion for selected articles. Article-level metrics track your real-world impact and clinical translation.
Author Support
Dedicated editorial team, language editing services, and responsive support throughout the publication journey from submission to promotion.
Prepare your manuscript following our Author Guidelines. Submit through either portal below. Our editorial team will confirm receipt within 48 hours and initiate expert oncology peer review promptly.
Drug Development
Novel therapeutic agents, mechanism of action studies, pharmacokinetics, early-phase trial results, and strategies for overcoming therapeutic resistance in cancer treatment.
Biomarker Discovery
Predictive and prognostic biomarkers, companion diagnostic development, liquid biopsy validation, and implementation of precision oncology in clinical practice settings.
JN welcomes submissions year-round with continuous publication for rapid dissemination of cancer research findings. Your discoveries deserve global visibility to accelerate translation to patient care.
Submit Your Cancer Research Today
Join leading oncologists advancing knowledge that transforms patient lives.
Submit your breakthrough cancer research today and join leading oncologists worldwide advancing patient care through rigorous science and collaboration.
Every manuscript submission contributes to the collective fight against cancer. Your research findings, clinical insights, and scientific discoveries deserve immediate global visibility through Open Access publishing.
Start your submission now—make a difference in cancer care.
